News of Note—Indian vaccine controversy, Genocea and more

newspapers
In this week's news of note, Genocea named two new executives. (Pixabay)

Here is some other vaccine news of note for the week:

> Officials in India inadvertently distributed a batch of tainted polio vaccines, but the WHO said the risk of infection for children was "minimal." Reuters article

> Genocea appointed Thomas Davis as its chief medical officer and Derek Meisner as its general counsel. Release

> OncBioMune kicked off a phase 2 trial of a candidate vaccine to treat prostate cancer. Release

> BlueWIllow Biologics picked up a Small Business Innovation Research grant from the National Institutes of Health to work on a chlamydia vaccine. Release

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.